HM Payson & Co’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$20.3K | – | 1158 |
|
|
2025
Q4 | $20.3K | Hold |
200
| – | – | ﹤0.01% | 834 |
|
|
2025
Q3 | $10.9K | Hold |
200
| – | – | ﹤0.01% | 895 |
|
|
2025
Q2 | $10.6K | Hold |
200
| – | – | ﹤0.01% | 849 |
|
|
2025
Q1 | $8.66K | Hold |
200
| – | – | ﹤0.01% | 870 |
|
|
2024
Q4 | $11.2K | Hold |
200
| – | – | ﹤0.01% | 831 |
|
|
2024
Q3 | $13.6K | Sell |
200
-435
| -69% | -$24.6K | ﹤0.01% | 813 |
|
|
2024
Q2 | $26.8K | Buy |
635
+435
| +218% | +$23.9K | ﹤0.01% | 710 |
|
|
2024
Q1 | $13.8K | Hold |
200
| – | – | ﹤0.01% | 790 |
|
|
2023
Q4 | $14.8K | Hold |
200
| – | – | ﹤0.01% | 781 |
|
|
2023
Q3 | $13.6K | Hold |
200
| – | – | ﹤0.01% | 786 |
|
|
2023
Q2 | $18.8K | Hold |
200
| – | – | ﹤0.01% | 739 |
|
|
2023
Q1 | $13.6K | Buy |
+200
| New | +$12.9K | ﹤0.01% | 769 |
|
|
2022
Q4 | – | Sell |
-200
| Closed | -$6K | – | 957 |
|
|
2022
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 832 |
|
|
2022
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 837 |
|
|
2022
Q1 | $14K | Sell |
200
-281
| -58% | -$20.5K | ﹤0.01% | 804 |
|
|
2021
Q4 | $37K | Buy |
481
+261
| +119% | +$23K | ﹤0.01% | 664 |
|
|
2021
Q3 | $21K | Hold |
220
| – | – | ﹤0.01% | 733 |
|
|
2021
Q2 | $27K | Sell |
220
-571
| -72% | -$68.1K | ﹤0.01% | 687 |
|
|
2021
Q1 | $104K | Hold |
791
| – | – | ﹤0.01% | 475 |
|
|
2020
Q4 | $105K | Sell |
791
-178
| -18% | -$21.5K | ﹤0.01% | 468 |
|
|
2020
Q3 | $99K | Buy |
969
+769
| +385% | +$66.4K | ﹤0.01% | 452 |
|
|
2020
Q2 | $17K | Sell |
200
-300
| -60% | -$24K | ﹤0.01% | 686 |
|
|
2020
Q1 | $29K | Hold |
500
| – | – | ﹤0.01% | 580 |
|
|
2019
Q4 | $46K | Hold |
500
| – | – | ﹤0.01% | 605 |
|
|
2019
Q3 | $45K | Hold |
500
| – | – | ﹤0.01% | 610 |
|
|
2019
Q2 | $59K | Buy |
+500
| New | +$50.4K | ﹤0.01% | 574 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
HM Payson & Co's EXAS Position: Q1 2026 in Review
HM Payson & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 200 shares — an estimated $20.3K sold.
HM Payson & Co first reported a position in EXAS in Q2 2019 and held it in 26 quarters. The position peaked at $105K in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- HM Payson & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- HM Payson & Co sold 200 Exact Sciences shares in Q1 2026, an estimated $20.3K.
- HM Payson & Co first reported a position in Exact Sciences in Q2 2019 and held it in 26 quarters.
- HM Payson & Co's Exact Sciences position peaked at $105K in Q4 2020.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on HM Payson & Co's 13F filing for Q1 2026, filed 13 Apr 2026.